04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Joining the other federal appellate panels to consider the issue, the U.S. Court of Appeals for the ...
Read More >
The European Court of Justice (ECJ) ruled on 14 May in Federacion de Servicios de Comisiones Obreras...
Read More >
On June 11, 2019 Governor Kay Ivey signed the Clarke-Figures Equal Pay Act into law. The new law mak...
Read More >
California Gov. Gavin Newsom signed Assembly Bill 5 (AB-5) on September 18, 2019, which adopts the “...
Read More >
On January 10, 2020 the United States Department of Justice (DOJ) and the Federal Trade Commission (...
Read More >
It's the end of the year and while everyone is busy, employers in California should be aware of new ...
Read More >